GRIN2B and Intellectual disability: Ser supplementation in a 5-year-old patient with GRIN2B-related developmental delay, intellectual disability, and autism spectrum disorder resulted in significant improvements in all neurodevelopmental assessments, suggesting that Ser supplementation could mitigate the neurological manifestations related to NMDA receptor dysfunction [105].